This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Summit Corporation Plc. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Renate Van Well: Innovator in Pharmaceutical Compounds
Introduction
Renate Van Well is a notable inventor based in Great Britain, recognized for her contributions to the field of pharmaceuticals. She has focused her research on developing compounds that are effective in treating infections caused by Clostridium difficile.
Latest Patents
Although Renate Van Well currently holds no patents, her work includes the disclosure of compounds for the treatment of Clostridium difficile-associated disease. These compounds are characterized by a specific formula and are designed to be used in various forms, including salts and prodrugs, to combat infections effectively.
Career Highlights
Renate is associated with Summit Corporation Plc, where she has been involved in significant research and development efforts. Her expertise in pharmaceutical compounds has positioned her as a valuable asset in her field.
Collaborations
Renate has collaborated with notable colleagues, including Peter David Johnson and Richard Vickers, contributing to a dynamic research environment that fosters innovation.
Conclusion
Renate Van Well's work in developing pharmaceutical compounds showcases her commitment to addressing critical health challenges. Her contributions, although not yet reflected in patents, highlight her potential impact in the field of medicine.